Drug profile · INN
miconazole nitrate
MONISTAT 7
miconazole nitrate (MONISTAT 7) is a cytochrome p450 51 inhibitor. Associated with Teva Pharma GmbH. Route of administration: topical. Current US regulatory status: approved.
Drug details — miconazole nitrate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
miconazole nitrate (MONISTAT 7) is a cytochrome p450 51 inhibitor. Associated with Teva Pharma GmbH. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Cytochrome P450 51 inhibitor
Primary target: Lanosterol 14-alpha demethylase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is miconazole nitrate?
miconazole nitrate (MONISTAT 7) is a cytochrome p450 51 inhibitor. Associated with Teva Pharma GmbH. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for miconazole nitrate?
MONISTAT 7 is a marketed brand name for miconazole nitrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of miconazole nitrate?
miconazole nitrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.